This study investigates advanced or metastatic castration-resistant prostate cancer, pancreatic cancer, and HPV-negative squamous cell carcinoma of the head and neck. The purpose of this study is to explore the effects of investigational medications in these conditions.
The study evaluates how well the investigational medications work together to target cancer cells. It looks at the safety and effectiveness of these medications in helping the body's immune system fight cancer.
- Who can participate: Adults with advanced castration-resistant prostate cancer, pancreatic cancer, or HPV-negative head and neck cancer may join. Participants should have a life expectancy of at least 3 months and meet specific health criteria.
- Study details: Participants will receive investigational medications and may undergo biopsies to provide tumor samples. A placebo is not involved in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand